Acute Care Volume 21, Issue 20

Medication Safety Alert! October 6, 2016

In this week's issue:

  • QuarterWatch™ (2016 Quarter 1 Data)
    • Lessons Learned from Withdrawal of the Zecuity Patch
    • Patient Difficulties Using the Tanzeum Pen
  • Don't bring controlled substances to the bedside or procedural area before they are ordered or needed
  • Industry, take notice (prefilled syringe label difficult to read)
  • Tamper evident ring on eye ointment cap can fall onto eye
  • Revision to drug name pairs with tall man letters
  • Quarterly Action Agenda (July - September 2016)
Featured article

The latest issue of ISMP’s QuarterWatch™ provides a review of new drug safety issues reflected in adverse drug events reported to the US Food and Drug Administration (FDA) during the first quarter of 2016. This report examines two signals for problems with devices that administer drugs to patients rather than the underlying risks associated with the drugs themselves:

  • ZECUITY (SUMAtriptan iontophoretic transdermal system), which uses small electrical currents to deliver SUMAtriptan through the skin to treat migraine headaches, was withdrawn after just 9 months on the market because of burns,...

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)